Insider Transactions in Q2 2024 at Nuvectis Pharma, Inc. (NVCT)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2024
|
James F Oliviero Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+34.16%
|
-
|
|
Jun 13
2024
|
Kenneth Hoberman Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+22.53%
|
-
|
|
Jun 13
2024
|
Matthew L. Kaplan Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+26.37%
|
-
|
|
May 14
2024
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
1,940
+0.06%
|
$11,640
$6.74 P/Share
|
|
May 10
2024
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
2,000
+0.06%
|
$12,000
$6.4 P/Share
|
|
May 10
2024
|
Shay Shemesh Chief Dev. & Ops. Officer |
BUY
Open market or private purchase
|
Direct |
1,113
+0.07%
|
$6,678
$6.32 P/Share
|
|
May 10
2024
|
Enrique Poradosu Chief Science & Business Off |
BUY
Open market or private purchase
|
Direct |
500
+0.03%
|
$3,000
$6.29 P/Share
|